Accelerated Corneal Cross-linking With Different Riboflavin Solutions

Summary

Following the Bunsen-Roscoe law, accelerated cross-linking protocols with higher irradiation intensities and shorter irradiation times have been introduced. In addition, new riboflavin solutions with HPMC (hydroxylpropyl methylcellulose) instead of dextran found its way into CXL-treatment. The aim of this trial is to evaluate clinical outcomes in an accelerated corneal collagen cross-linking protocol with different riboflavin solutions.

Timeline

Start

2016-09-19

Primary completion

2020-03-30

Completion

2020-03-30

Drugs

Indications